Insider Title Company Date Price Return Shares Value
Martin Michael Robert Chief Business Officer Aurinia Pharmaceuticals Inc. (AUPH) 2022-11-07 $5.16 33.9% 30,000 $154,800
Return Profit / (loss) Cost
Total 33.9% $52,500 $154,800